Publications by authors named "Nishimoto H"

Background: The medial ulnar collateral ligament (UCL) of the elbow joint is the primary restraint to valgus stress during the throwing motion. The flexor pronator muscles (FPMs) also stabilize the elbow joint against valgus forces; however, assessment of FPM stiffness in baseball players has been limited.

Purpose: To use ultrasound shear wave elastography (USWE) to evaluate the change in tissue elasticity of the FPMs due to pitching.

View Article and Find Full Text PDF
Article Synopsis
  • A study explored the use of high-dose-rate interstitial brachytherapy (HDR-ISBT) as palliative treatment for an 81-year-old male with base of tongue cancer, following prior radiation and treatment.
  • The patient underwent a lower-dose external beam radiotherapy (ERT) followed by a single-fraction HDR-ISBT booster, with precautions taken to minimize infection and bleeding.
  • Post-treatment results showed significant tumor reduction, pain relief, and no complications after nearly three years, indicating HDR-ISBT could be an effective palliative care option for patients in similar situations.
View Article and Find Full Text PDF

Introduction: The trabecular bone score (TBS) has emerged as a convenient measure for assessing the microstructure of trabecular bone in the second through fourth lumbar vertebrae (L2-4) and can be conducted concurrently with bone mineral density (BMD) assessment. This study was performed to evaluate changes in BMD and the TBS during ADT for prostate cancer.

Materials And Methods: Consecutive patients who had prostate cancer without bone metastases at Kobe University Hospital were studied from March 2020 to December 2021.

View Article and Find Full Text PDF

Background: Multidrug chemotherapy for Ewing sarcoma can lead to severe myelosuppression. We proposed two clinical questions (CQ): CQ #1, "Does primary prophylaxis with G-CSF benefit chemotherapy for Ewing sarcoma?" and CQ #2, "Does G-CSF-based intensified chemotherapy improve Ewing sarcoma treatment outcomes?".

Methods: A comprehensive literature search was conducted in PubMed, Cochrane Library, and Ichushi web databases, including English and Japanese articles published from 1990 to 2019.

View Article and Find Full Text PDF

Introduction: Chemotherapy for breast cancer can cause neutropenia, increasing the risk of febrile neutropenia (FN) and serious infections. The use of granulocyte colony-stimulating factors (G-CSF) as primary prophylaxis has been explored to mitigate these risks. To evaluate the efficacy and safety of primary G-CSF prophylaxis in patients with invasive breast cancer undergoing chemotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • G-CSF is a supportive treatment used to prevent severe complications from chemotherapy in patients with non-round cell soft tissue sarcomas (NRC-STS), with two key clinical questions raised about its effectiveness.
  • A literature review found a limited number of studies that addressed these questions, resulting in only a few articles being included for analysis.
  • The conclusion suggests that there is insufficient scientific evidence to confirm the benefits of G-CSF prophylaxis in improving treatment outcomes for NRC-STS, indicating the need for further research.
View Article and Find Full Text PDF
Article Synopsis
  • Relapsed or refractory acute myeloid leukemia (AML) has poor outcomes, and the impact of granulocyte colony-stimulating factor (G-CSF) combined with chemotherapy is still debated.
  • A systematic literature review and meta-analysis were conducted, assessing 11 studies, which suggested that G-CSF priming did not significantly improve response rates or overall survival for AML patients, although there was a slight trend towards lower relapse rates.
  • Certain groups, particularly those with intermediate cytogenetic risk and those receiving high-dose cytarabine, showed prolonged overall survival with G-CSF priming, indicating the need for further research to find the most suitable patients for this treatment approach.*
View Article and Find Full Text PDF

Traditionally, angle measurements have been performed using a goniometer, but the complex motion of shoulder movement has made these measurements intricate. The angle of rotation of the shoulder is particularly difficult to measure from an upright position because of the complicated base and moving axes. In this study, we attempted to estimate the shoulder joint internal/external rotation angle using the combination of pose estimation artificial intelligence (AI) and a machine learning model.

View Article and Find Full Text PDF

MediaPipe Hand (MediaPipe) is an artificial intelligence (AI)-based pose estimation library. In this study, MediaPipe was combined with four machine learning (ML) models to estimate the rotation angle of the thumb. Videos of the right hands of 15 healthy volunteers were recorded and processed into 9000 images.

View Article and Find Full Text PDF

Background: Febrile neutropenia represents a critical oncologic emergency, and its management is pivotal in cancer therapy. In several guidelines, the use of granulocyte colony-stimulating factor (G-CSF) in patients with chemotherapy-induced febrile neutropenia is not routinely recommended except in high-risk cases. The Japan Society of Clinical Oncology has updated its clinical practice guidelines for the use of G-CSF, incorporating a systematic review to address this clinical question.

View Article and Find Full Text PDF

: Androgen deprivation therapy (ADT) for prostate cancer has greatly improved treatment outcomes. As patient survival rates have increased, reports of decreased bone density and increased bone fractures as side effects of ADT have emerged. The prevalence of osteoporosis in Japanese men was 4.

View Article and Find Full Text PDF
Article Synopsis
  • Granulocyte colony-stimulating factor (G-CSF) is used to prevent febrile neutropenia (FN) in cancer patients, with two types available in Japan: long-lasting PEG G-CSF and short-term non-PEG G-CSF.
  • A systematic review of studies found that PEG G-CSF significantly reduces the incidence of FN compared to non-PEG G-CSF, based on a thorough analysis of 23 articles.
  • The study concludes that a single dose of PEG G-CSF is preferred for primary prevention of FN, as it shows stronger evidence compared to multiple doses of non-PEG G-CSF.
View Article and Find Full Text PDF
Article Synopsis
  • Granulocyte colony-stimulating factor (G-CSF) is used to reduce the risk of neutropenia and infections during cancer chemotherapy, but its effectiveness for digestive system tumors is still uncertain.
  • A systematic review was conducted to evaluate the effectiveness of G-CSF as primary prophylaxis and its impact on the intensity of chemotherapy for various digestive system tumors.
  • The findings indicated that while G-CSF's use in colorectal cancer chemotherapy is inappropriate, there wasn't enough data to make strong recommendations for other types of digestive cancers.
View Article and Find Full Text PDF

Background: Docetaxel (DTX) is commonly used as a primary chemotherapy, and cabazitaxel (CBZ) has shown efficacy in patients who are DTX resistant. Primary prophylactic granulocyte colony stimulating factor (G-CSF) therapy is currently used with CBZ treatment in routine clinical care in Japan.

Methods: In this study, we performed a systematic review following the Minds guidelines to investigate the effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for prostate cancer and to construct G-CSF guidelines for primary prophylaxis use during chemotherapy.

View Article and Find Full Text PDF

Electrode montage optimization for transcranial electric stimulation (tES) is a challenging topic for targeting a specific brain region. Targeting the deep brain region is difficult due to tissue inhomogeneity, resulting in complex current flow. In this study, a simplified protocol for montage optimization is proposed for multichannel tES (mc-tES).

View Article and Find Full Text PDF
Article Synopsis
  • The review examines the optimal timing for administering prophylactic pegylated granulocyte colony-stimulating factor (G-CSF) during cancer chemotherapy, focusing mainly on Day 2 versus Days 3-5.
  • Out of 300 studies initially reviewed, only four met the criteria, suggesting a potential increase in febrile neutropenia when G-CSF is given on Days 3-5 compared to Day 2, but no significant differences in overall survival or infection-related mortality were found.
  • The findings indicate weak recommendations for both timing options and emphasize the need for more research to make clearer guidelines for pegylated G-CSF administration.
View Article and Find Full Text PDF

Granulocyte colony-stimulating factor (G-CSF) decreases the incidence, duration, and severity of febrile neutropenia (FN); however, dose reduction or withdrawal is often preferred in the management of adverse events in the treatment of urothelial cancer. It is also important to maintain therapeutic intensity in order to control disease progression and thereby relieve symptoms, such as hematuria, infection, bleeding, and pain, as well as to prolong the survival. In this clinical question, we compared treatment with primary prophylactic administration of G-CSF to maintain therapeutic intensity with conventional standard therapy without G-CSF and examined the benefits and risks as major outcomes.

View Article and Find Full Text PDF

A combination of osteotomy and ligament reconstruction is recommended for posterolateral rotatory instability (PLRI) with large cubitus varus deformities. There is a lack of reports regarding ligament donor selection for ligament reconstruction of PLRI with cubitus varus. Two cases of PLRI with cubitus varus have been described.

View Article and Find Full Text PDF

Although granulocyte colony-stimulating factor (G-CSF) reduces the incidence, duration, and severity of neutropenia, its prophylactic use for acute myeloid leukemia (AML) remains controversial due to a theoretically increased risk of relapse. The present study investigated the effects of G-CSF as primary prophylaxis for AML with remission induction therapy. A detailed literature search for related studies was performed using PubMed, Ichushi-Web, and the Cochrane Library.

View Article and Find Full Text PDF

Background: Some patients with food protein-induced enterocolitis (FPIES)-like allergy do not completely fulfill the diagnostic criteria of the international consensus guideline for FPIES. However, it is unclear whether such FPIES-like patients represent a completely different population from FPIES.

Objective: This study aimed to clarify differences in characteristics between patients with FPIES who fully met diagnostic criteria and those who partly met them.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the effectiveness of the new short-acting benzodiazepine remimazolam for successfully inserting i-gels, combined with fentanyl, in 30 patients.
  • Participants were divided into five groups, each receiving different doses of remimazolam, and the success of i-gel insertion was assessed after a set time.
  • The estimated effective effect-site concentrations of remimazolam necessary for successful i-gel insertion were found to be 0.88 µg/ml (50% success) and 1.57 µg/ml (95% success).
View Article and Find Full Text PDF
Article Synopsis
  • G-CSF is used to prevent febrile neutropenia (FN) in cancer patients, but there's limited evidence on its effectiveness specifically for lung cancer.
  • Studies on non-small-cell lung cancer (NSCLC) showed some potential benefits in reducing FN incidence, while small-cell lung cancer (SCLC) showed no significant impact.
  • Overall, there is not enough data to make strong recommendations for G-CSF use in lung cancer, but it may be considered for certain NSCLC patients on specific therapies.
View Article and Find Full Text PDF

Background: Advanced glycation end products (AGEs) are compounds formed due to aging and diabetes mellitus (DM). They activate NADPH oxidase (NOX) by binding to their receptors, thereby increasing the production of reactive oxygen species (ROS), which cause oxidative stress. In this study, we investigated the effects of AGEs on the tissues of the shoulder joint (such as rotator cuff synovium, and capsule) in patients with DM having rotator cuff tears.

View Article and Find Full Text PDF

Background: Postoperative rotator cuff retear after arthroscopic rotator cuff repair (ARCR) is still a major problem. Various risk factors such as age, gender, and tear size have been reported. Recently, magnetic resonance imaging-based stump classification was reported as an index of rotator cuff fragility.

View Article and Find Full Text PDF